Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
US Army
Accenture
Deloitte
Chubb
Moodys
Fuji
McKesson
Cipla

Generated: November 15, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: insulin glargine recombinant

« Back to Dashboard

insulin glargine recombinant

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sanofi Aventis Us LANTUS insulin glargine recombinant INJECTABLE;INJECTION 021081 NDA sanofi-aventis U.S. LLC 0088-2219-00 1 SYRINGE in 1 CARTON (0088-2219-00) > 3 mL in 1 SYRINGE
Sanofi Aventis Us LANTUS insulin glargine recombinant INJECTABLE;INJECTION 021081 NDA sanofi-aventis U.S. LLC 0088-2219-05 5 SYRINGE in 1 CARTON (0088-2219-05) > 3 mL in 1 SYRINGE
Sanofi Aventis Us LANTUS insulin glargine recombinant INJECTABLE;INJECTION 021081 NDA sanofi-aventis U.S. LLC 0088-2220-33 1 VIAL, GLASS in 1 CARTON (0088-2220-33) > 10 mL in 1 VIAL, GLASS
Sanofi Aventis Us LANTUS insulin glargine recombinant INJECTABLE;INJECTION 021081 NDA sanofi-aventis U.S. LLC 0088-5020-01 1 SYRINGE in 1 PACKAGE (0088-5020-01) > 3 mL in 1 SYRINGE
Sanofi Aventis Us LANTUS insulin glargine recombinant INJECTABLE;INJECTION 021081 NDA sanofi-aventis U.S. LLC 0088-5020-05 5 SYRINGE in 1 PACKAGE (0088-5020-05) > 3 mL in 1 SYRINGE
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chubb
US Department of Justice
Queensland Health
US Army
Mallinckrodt
Chinese Patent Office
Boehringer Ingelheim
Harvard Business School